Stopped
GB002 · Pulmonary Arterial Hypertension (PAH)
Trial terminated
Also in this update: Primary completion date changed from estimate of Dec 2027 to Sep 9, 2026
Gossamer Bio USA, Inc.Phase 2 NCT04816604 Registry history of NCT04816604 on ClinicalTrials.gov (opens the registry)